These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1406777)

  • 41. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
    Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
    Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy.
    Tremblay JP; Bouchard JP; Malouin F; Théau D; Cottrell F; Collin H; Rouche A; Gilgenkrantz S; Abbadi N; Tremblay M
    Neuromuscul Disord; 1993; 3(5-6):583-92. PubMed ID: 8186717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy.
    Law PK; Bertorini TE; Goodwin TG; Chen M; Fang QW; Li HJ; Kirby DS; Florendo JA; Herrod HG; Golden GS
    Lancet; 1990 Jul; 336(8707):114-5. PubMed ID: 1697393
    [No Abstract]   [Full Text] [Related]  

  • 44. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy.
    Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH
    Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fate of individual myoblasts after transplantation into muscles of DMD patients.
    Gussoni E; Blau HM; Kunkel LM
    Nat Med; 1997 Sep; 3(9):970-7. PubMed ID: 9288722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular therapy for muscular dystrophy].
    Shimizu Y; Takeda S
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():650-3. PubMed ID: 20976941
    [No Abstract]   [Full Text] [Related]  

  • 47. The principles and practice of myoblast transfer.
    Karpati G
    Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156
    [No Abstract]   [Full Text] [Related]  

  • 48. First human myoblast transfer therapy continues to show dystrophin after 6 years.
    Law PK; Goodwin TG; Fang Q; Hall TL; Quinley T; Vastagh G; Duggirala V; Larkin C; Florendo JA; Li L; Jackson T; Yoo TJ; Chase N; Neel M; Krahn T; Holcomb R
    Cell Transplant; 1997; 6(1):95-100. PubMed ID: 9040960
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in Muscular Dystrophies.
    Kang PB; Griggs RC
    JAMA Neurol; 2015 Jul; 72(7):741-2. PubMed ID: 25985443
    [No Abstract]   [Full Text] [Related]  

  • 50. Gene therapy for muscle diseases.
    Coovert DD; Burghes AH
    Curr Opin Neurol; 1994 Oct; 7(5):463-70. PubMed ID: 7804468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 52. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 53. The muscular dystrophies.
    Dubowitz V
    Postgrad Med J; 1992 Jul; 68(801):500-6. PubMed ID: 1437944
    [No Abstract]   [Full Text] [Related]  

  • 54. Myoblast transplantation in inherited myopathies.
    Morgan JE; Watt DJ
    Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544
    [No Abstract]   [Full Text] [Related]  

  • 55. [Reflexions apropos of recent progresses in molecular genetics of myopathies].
    Kaplan JC
    Arch Pediatr; 1995 Aug; 2(8):715-8. PubMed ID: 7550833
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR
    Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150
    [No Abstract]   [Full Text] [Related]  

  • 57. The DMD gene promoter: a potential role in gene therapy.
    Ray PN; Klamut HJ; Worton RG
    Adv Exp Med Biol; 1990; 280():107-11; discussion 111-2. PubMed ID: 2248131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Report of the MDA Gene Therapy Conference, Tucson, Arizona, September 27-28, 1991.
    Rossiter BJ; Stirpe NS; Caskey CT
    Neurology; 1992 Jul; 42(7):1413-8. PubMed ID: 1620357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myoblast transfer therapy. Proceedings of a Muscular Dystrophy Association International Conference. June 10-12, 1989, New York, New York.
    Adv Exp Med Biol; 1990; 280():1-308. PubMed ID: 1978965
    [No Abstract]   [Full Text] [Related]  

  • 60. Purification and proliferation of human myoblasts isolated with fluorescence activated cell sorting.
    Blau HM; Webster C; Pavlath GK
    Adv Exp Med Biol; 1990; 280():97-100. PubMed ID: 2248160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.